FDA 483 - Biomat USA Inc - December 09, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Biomat USA, Inc. in Zanesville, OH, a source plasmapheresis center, received a Form 483 with four observations. The inspection revealed significant issues including failures in ensuring sterile plasma separation, maintaining accurate quality control records, adhering to manufacturer instructions for reagent handling, and following written standard operating procedures for blood component collection. These observations indicate deficiencies in critical aspects of plasma processing and quality assurance.
- Person
ID · ec367322-217f-47ed-83de-fe06a3f85225